PharmExec
CONTINUE TO SITE >

OR WAIT 15 SECS

Pharmaceutical Executive-06-01-2020

Pharmaceutical Executive

Better ESG Communication with Investors

June 12, 2020

Columns

40

6

Guidance addresses struggles in reporting non-financial performance.

Will the Biopharma Leaders Please Take the Stage!

June 12, 2020

Columns

40

6

Now is the time, the world is listening.

The Specter of Compulsory Licensing Haunts Vaccine Debate

June 11, 2020

Columns

40

6

Industry prospects at mercy of public discourse, policy shifts.

Pivotal Moments: How Leaders Can Prepare for the Unexpected

June 11, 2020

Columns

40

6

Balancing bold and pragmatic approaches during times of crisis.

Spotlight on Science Gives Public New Perspective

June 10, 2020

Features

40

6

As government turns to the pharma industry not just for therapies or a vaccine but for tests and data to evaluate these treatments, people are receiving an education.

Rare Insights: Arndt Rolfs, CENTOGENE

June 10, 2020

Features

40

6

Pharm Exec speaks with Arndt Rolfs, CEO and founder of CENTOGENE, who discusses his company’s rise from a small genetic diagnostics startup to a global organization focused on advancing the understanding of the pathophysiology of rare hereditary diseases.

Pharmaceutical Executive, June 2020 Issue (PDF)

June 01, 2020

Issue PDF

40

6

Click the title above to open the Pharmaceutical Executive June 2020 issue in an interactive PDF format.